Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division of the Swiss pharmaceutical giant Novartis. The deal, valued at approximately $1 billion, involves the purchase of Sandoz’s dermatology business and a diverse portfolio of oral solid products, along with commercial and manufacturing infrastructure. The transaction terms […]
In a strategic move within the pharmaceutical industry, Sandoz US, a subsidiary of the Swiss-based Novartis, has announced the sale of its dermatology and oral solids businesses to Aurobindo Pharma, an Indian pharmaceutical giant. The deal, which includes a $900 million cash payment and potential earn-outs of $100 million, marks a significant reshaping of Sandoz’s […]
Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an Australian biotech company, for AUD 502 million (approximately $394 million). This acquisition is set to significantly enhance Merck’s portfolio in the burgeoning field of immuno-oncology. Strategic Expansion of Immuno-Oncology Pipeline: Through this acquisition, Merck aims to expand […]
In a significant move within the pharmaceutical sector, Shanghai Pharmaceuticals Holding Co. has agreed to purchase the Chinese pharmaceutical distribution business of US-based Cardinal Health for $557 million. The deal, announced amid looming drug distribution reforms in China, marks a major shift for Cardinal Health as it reevaluates its growth strategy in the region. Details […]